Lincoln Financial Group (NYSE:LNC) delivered a strong fourth-quarter performance on Thursday, Feb. 12, 2026, beating Wall Street’s profit estimates as the "silver tsunami" of retiring Americans fueled record-high account balances across its core insurance and retirement segments.
West Pharmaceutical Services (NYSE:WST) shares gained momentum Thursday after the injectable-solution leader posted a fourth-quarter earnings beat and provided a bullish 2026 outlook, fueled by the explosive growth of GLP-1 "obesity" drugs and a massive jump in free cash flow.
Check Point Software Technologies (NASDAQ:CHKP) reported strong financial results for the fourth quarter and full year ended December 31, 2025, reflecting continued demand for its comprehensive cybersecurity solutions.
Himax Technologies (NASDAQ:HIMX) reported fourth-quarter results that landed at the high end of its own guidance, though the semiconductor firm signaled a cautious start to 2026 as the global automotive market continues to navigate a thicket of macroeconomic headwinds.
The January US jobs report surprised to the upside, adding 130,000 roles as unemployment dipped to 4.3% and wages stayed contained.
Palo Alto Networks (NASDAQ:PANW) finalized its acquisition of CyberArk Software in a landmark $25 billion transaction, marking a historic shift in the cybersecurity landscape.
Fortis (NYSE:FTS), a leading North American regulated electric and gas utility, reported financial results for the full year ended December 31, 2025, and announced a significant capital investment plan while reaffirming long-term dividend growth guidance.
New York-based LXP Industrial Trust (NYSE:LXP), a focused industrial REIT specializing in high-quality warehouse and distribution facilities, reported financial and operational results for the fourth quarter and full year ended December 31, 2025.
New York-based Ridgepost Capital (NYSE:RPC), a diversified alternative asset manager, reported strong growth and strategic progress for the fourth quarter and full year ended December 31, 2025.
Agios Pharmaceuticals (NASDAQ:AGIO) today released financial results and business updates for the fourth quarter and full year ended December 31, 2025, highlighting regulatory progress and commercial momentum in rare blood disorders.
Vontier (NYSE:VNT) today revealed fourth-quarter and full-year 2025 results that exceeded Wall Street estimates, propelled by a rapid shift toward digital services in the mobility ecosystem.
Zebra Technologies (NASDAQ:ZBRA) shares jumped nearly 9% in early trading Thursday after the company paired a fourth-quarter revenue beat with an optimistic 2026 forecast and a massive new $1 billion share repurchase authorization.
